| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | ML239 | CTRPv2 | pan-cancer | AAC | 0.25 | 6e-12 |
| mRNA | FK866 | GDSC1000 | pan-cancer | AAC | 0.21 | 7e-11 |
| mRNA | TL-2-105 | GDSC1000 | pan-cancer | AAC | 0.2 | 1e-09 |
| mRNA | masitinib | GDSC1000 | pan-cancer | AAC | 0.2 | 3e-09 |
| mRNA | NPK76-II-72-1 | GDSC1000 | pan-cancer | AAC | 0.17 | 8e-09 |
| mRNA | Axitinib | CTRPv2 | pan-cancer | AAC | 0.2 | 2e-08 |
| mRNA | nelarabine | CTRPv2 | pan-cancer | AAC | 0.22 | 4e-08 |
| mRNA | RG-108 | CTRPv2 | pan-cancer | AAC | 0.19 | 2e-07 |
| mRNA | LY-2183240 | CTRPv2 | pan-cancer | AAC | 0.17 | 5e-07 |
| mRNA | NG-25 | GDSC1000 | pan-cancer | AAC | 0.15 | 6e-07 |